Список проголосовавших за комментарий " Gapping up/down: POLA +26% and MVIS +18% after earnings/updates; AA +2%, NFLX +1% and HPQ +1% after upgrades; EU banks trading lower, GPRO -3% after dg at GS<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>POLA</strong> +25.9%, <strong>MVIS</strong> +17.9%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>CNCE</strong> +33.7% (to sell CTP-656 to Vertex Pharmaceuticals (VRTX) for an upfront payment of $160 mln in cash with the potential for $90 mln in future regulatory approval milestone payments, also reported earnings)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>TGTX</strong> +66.4% (announces 'positive' topline results from its Phase 3 GENUINE clinical trial of TG-1101 plus ibrutinib)</li><li><strong>PTCT</strong> +14.7% (FDA has acknowledged the filing over protest of PTC's New Drug Application for Translarna)</li><li><strong>ADXS</strong> +9% (announces FDA acceptance of IND for personalized neoepitope immunotherapy, ADXS-NEO)</li><li><strong>NOVN</strong> +8.8% (provides update on SB204 development program, intends to proceed with the SB204 development program)</li><li><strong>SDRL</strong> +8% (modestly rebounding following last week's 37% decline)</li><li><strong>CXRX</strong> +6.8% (US district court awarded the co treble damages of $2.2 mln, an increase from the original damages award of $733k)</li><li><strong>IMGN</strong> +4.7% (files for $200 mln mixed securities shelf offering)</li><li><strong>RRC</strong> +3.6% (Barron's profiles positive view on Range Resources)</li><li><strong>XRX</strong> +3% (Barron's profiles positive view on Xerox)</li><li><strong>DBVT</strong> +2.7% (reports results of 'Viaskin Peanut' study suggesting lasting response and favorable safety profile)</li><li><strong>RRTS</strong> +2.2% (Elliott Associates Friday increased its passive stake to 7.5%)</li><li><strong>VRX</strong> +1.8% (completes about $1.1 bln pay down of senior secured term loans from divestitures; to seek refinancing & amendment of credit agreement)</li><li><strong>AMD</strong> +1% (Mubadala Development Company PJSC proposes the sale of 45 mln shares under form 144)</li><li><strong>UBNT</strong> +0.8% (approved $50 mln stock repurchase program)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>AA</strong> +2.1% (upgraded to Buy from Neutral at Goldman)</li><li><strong>NFLX</strong> +1.4% (upgraded to Buy from Neutral at UBS)</li><li><strong>HPQ</strong> +0.9% (upgraded to Outperform from Market Perform at Wells Fargo)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>AFI</strong> -12.3%</li></ul><p><strong>Select EU financial related names showing weakness in sympathy with DB (EUR8 bln capital raise)</strong> :</p><ul><li><strong>CS</strong> -3.4%, <strong>RBS</strong> -2%, <strong>LYG</strong> -1.5%</li></ul><p><strong>Select metals/mining stocks trading lower following China's lowered GDP outlook to ~+6.5%</strong>:</p><ul><li><strong>HMY</strong> -2.5%, <strong>FCX</strong> -2.5%, <strong>BBL</strong> -2.5%, <strong>X</strong> -2.5%, <strong>RIO</strong> -2.1%, <strong>BHP</strong> -1.9%, <strong>AKS</strong> -1.7%, <strong>MT</strong> -1.2%, <strong>AU</strong> -1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>DRYS</strong> -8% (discloses stock purchase agreement update)</li><li><strong>TSN</strong> -2.4% (WSJ discusses that bird flu was found in chicken farm linked to Tyson Foods)</li><li><strong>CMG</strong> -1.3% (files for 2,882,463 share common stock offering by selling shareholder)</li><li><strong>TEVA</strong> -1.1% (continued weakness)</li><li><strong>DB</strong> -0.9% (announces capital increase of EUR8 bln, refines strategy; announces new financial targets)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>GPRO</strong> -2.7% (downgraded to Sell from Neutral at Goldman)</li><li><strong>MET</strong> -1.1% (downgraded to Neutral from Buy at BofA/Merrill)</li><li><strong>PG</strong> -0.8% (downgraded to Neutral from Buy at B. Riley)</li></ul>"